HOXA9 and acute myeloid leukemia: In summary, our results demonstrate that enhanced Syk signaling in the presence of Meis1 represents a regulatory feedback mechanism of leukemogenesis in Hoxa9-driven AML that renders these cells sensitive to Syk inhibition.